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Introduction: Teeth with irreversible pulpitis usually undergo root canal therapy (RCT). This
treatment modality is often considered disadvantageous as it removes vital pulp tissue and weakens
the tooth structure. A relatively new concept has risen which suggests vital pulp therapy (VPT) for
irreversible pulpitis. VPT with calcium enriched mixture (VPT/CEM) has demonstrated favorable
treatment outcomes when treating permanent molars with irreversible pulpitis. This study aims to
compare patient related factors, safety and organizational consideration as parts of health technology
assessment (HTA) of the new VPT/CEM biotechnology when compared with RCT. Materials and
Methods: Patient related factors were assessed by looking at short- and long-term clinical success;
safety related factors were evaluated by a specialist committee and discussion board involved in
formulating healthcare policies. Organizational evaluation was performed and the social
implications were assessed by estimating the costs, availability, accessibility and acceptability. The
impact of VPT/CEM biotechnology was assessed by investigating the incidence of irreversible
pulpitis and the effect of this treatment on reducing the burden of disease. Results: VPT/CEM
biotechnology was deemed feasible and acceptable like RCT; however, it was more successful,
accessible, affordable, available and also safer than RCT. Conclusion: When considering
socioeconomic implications on oral health status and oral health-related quality of life of VPT/CEM,
the novel biotechnology can be more effective and more efficient than RCT in mature permanent
molars with irreversible pulpitis.
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ral health can significantly affect quality of life [1].
Dental caries is one of the most common chronic
diseases of adults and children in both developed
and developing nations, even though the etiology and
prevention of this disease is well known. Caries can affect
growth and well being in young children [2], and is the most
common cause of head and neck pain in humans [3].
Patients, especially from deprived backgrounds, often
avoid dental treatment as the costs incurred can be severe [4],
and the only alternative to root canal therapy (RCT) may be
tooth extraction [5]. According to current evidence based
protocols, RCT is indicated once the pulp is diagnosed with
irreversible pulpitis and in teeth with necrotic pulps [6]. The
fair prognosis of RCT (68-85%) is documented [7]. Besides
being rather expensive, complicated, time-consuming, and
non-conservative, RCT has the capacity of weakening the
tooth structure and thus can initiate a restorative spiral [8].
Moreover, it is often considered a difficult procedure for
general dentists.
Although irreversible pulpitis is often associated with
spontaneous or prolonged pain after a specific trigger, it can
sometimes present without any symptoms [9]. In other
words, correlation of clinical signs and symptoms with
histopathological status of the pulp is not always accurate.
Ideally, treatment of carious vital teeth should aim to
alleviate pain, remove affected/infected tissue, conserve pulp
vitality and finally restore function and aesthetics. Previous
reports have indicated that vital pulp therapy (VPT) can only
O
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be carried out on reversibly inflamed pulps of mature teeth that
are traumatically or iatrogenically exposed [10], or in cariously
exposed immature teeth [11]. However, some schools of
thought have advocated the use of VPT on mature permanent
teeth diagnosed with irreversible pulpitis [12-15]. During VPT,
the infected dentin, bacteria/their byproduct and also the
affected pulp tissue are removed. The remaining pulp is sealed
with a biocompatible material, and so pulp vitality is
maintained. Pulpotomy has been successful in immature teeth
with traumatically or cariously exposed pulps [16, 17].
However, the use of this treatment in mature permanent teeth
has been controversial [11]. The one- and two-year extensive
multi-centered non-inferiority randomized clinical trials that
have been assessed here, have shown radiographic and clinical
success with VPT using a bio-regenerative endodontic
material, calcium enriched mixture cement (VPT/CEM) [18,
19]. The size of the study and results attained in the clinical
trials are more than adequate for assessing effectiveness and
efficacy of this novel bio-technology [20]. Therefore,
assessment of this new biotechnology may generally prove to
be invaluable for oral healthcare and maintaining pulp vitality.
There are ~6000 government funded primary dental care
centers in Iran which do not even provide RCT for their
patients; moreover, not all general dentist (GD) can perform
RCT to acceptable standards [21]. In this health technology
assessment (HTA), we aimed to compare VPT/CEM versus
RCT in teeth diagnosed with irreversible pulpitis.
Material and Methods
Based on the established format for reporting HTA, this
study assessed the implementation of VPT/CEM technology
from different aspects such as effectiveness, safety (possible
risks), organizational and social implications [22-24].
Phase I was patient based, where clinical success and
reduction/elimination of sign/symptoms as well as level of
evidence of the clinical trial was assessed; in Phase II safety
and the risks of the technology were evaluated; and finally in
Phase III socio-economic (i.e. impact/need, availability and
applicability/feasibility) and dental health policy making
were addressed. Moreover, a critical appraisal was made of
intervention and clinical results to assess the organizational
and social implications.
Setting and participants
This health technology assessment intends to evaluate a
multicenter randomized clinical trial (with non-inferiority
design) that was conducted in Iran. This study has six-,
twelve- and twenty four-month results; therefore the results
analyzed for HTA would provide a high level of evidence.
Details of the trial can be found in the previously published
articles [18, 19, 25]. Briefly, participants in the trial were
patients presenting to 23 University dental clinics throughout
4 states, diagnosed with caries extending to the pulp and
irreversible pulpitis in mature molars after radiographic and
clinical examinations. Considering that this was a national
project, the patients can be deemed a mixed sample.
Intervention
In the RCT group, the treatment was conducted using
step-back technique. To assess the novel health
biotechnology, VPT/CEM was the test group; treatment
was carried out as described previously [18].
Phase I: Main outcome measure
Evaluation of the efficacy of a clinical trial is usually based on the
subjective and objective short- and intermediate-term outcome
measures; for example the patients’ signs and symptoms,
experimental results or the absence/presence of disease. The
long-term outcome/prognosis are based on patients’ health and
wellbeing; consequently quality of life, functionality, and death
are less likely to be evaluated in this type of study [26]. It can be
argued that tooth retention will indeed improve the quality of
life and functionality of the individual. The efficacy of the
VPT/CEM new biotechnology is based on reduction or
elimination of pain (short-term) and maintaining the tooth
vitality and functionality (intermediate/long-term outcome).
Pain is one of the most common reasons for patients to
recourse to the dental clinics, especially with so called
irreversible pulpitis. Intervention with pulpectomy and if
time permits, RCT, results in reduction or suspension of
pain. In one study, pain outcome measures were assessed
preoperatively as well as 6, 12, 36, 48, and 60 h and 3 to 7
days postoperatively using quantified numerical pain rating
scale (NRS) [25]. Based on the reported pain scale, the
postoperative continuity of moderate to severe pain in h, the
degree of pain reduction in the first 24 h, the time taken to
reach pain free status and the number of patients that had no
pain, were recorded. Time taken to reach pain free status for
the two groups was analyzed using the Kaplan-Meier Test.
Clinical and radiographic evaluations were conducted at
regular intervals as described in previous publications, and
the clinical subjective symptoms and objective observation of
inflammation and/or infections were made [18, 19].
Objective signs including abscess, swelling, sinus tract,
redness, and tenderness were examined. Radiographic
assessment was made and the results were divided into the
following categories; teeth with normal contour and width of
periodontal ligament (PDL) were termed “healed”, teeth with
a clearly decreased size of the periapical radiolucency were
judged as “healing”, and teeth with unchanged, increased, or
new periapical radiolucency were categorized as “failed”.
The reported non-inferiority clinical trials were assessed
using the standardized CONSORT check list [18, 19, 25]. The
levels of evidence (LoE, Oxford), and therefore clinical and
social significance was also assessed.
Phase II: Safety measures
Most HTA studies have been based on medical
biotechnology rather than dental technology. Therefore, to
accurately verify and apply these techniques, expert opinion
was elicited where formal evidence was not available. A
committee and discussion board was established with
representatives from Center of Clinical Excellence (CCE),
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experts in the field of HTA, the researchers, medical
professionals involved in formulating healthcare policies, and
endodontists with no material/scientific interest in the
research. They were requested to discuss and assess the safety
margins of this new endodontic biotechnology in vital dental
tissue based on published evidence and expert opinion.
Ultimately, they were to reach definitive conclusions through
focused group discussions.
Phase III: Organizational measures
Several measurements were considered for assessing the
organizational aspects of the HTA including access, availability
and cost. Organizational and professional implications can be
addressed with system-related outcomes, such as required
personnel. Organizational measures (e.g. access) affect the
feasibility of implementation of a new technology and the
degree of effectiveness following implementation; i.e. human
resource or educational prerequisites must be available and
accessible. These measures were defined in the same
committee and discussion board that assessed the safety
margins. According to their consensus, the proposed
endodontic biotechnology which aims to attain non-
inferiority/equivalency and ultimately superiority, should
overcome the limitations of RCT in the fields below.
Access
Different aspects should be considered to assure that a
technology is accessible; prerequisites for its implementation
should be available and the cost barriers should be considered.
a) Availability of technique
For this clinical trial, both RCT and pulpotomy had to be
available treatments. That is, financial support for expendable
and non expendable goods, trained dental professionals, and
the right equipment (radiographic units, dental units, dental
equipment and materials) had to be available for smooth
running of this treatment method especially in deprived rural
regions of Iran. The availability of the new biotechnology was
then to be compared to RCT within the centers.
b) Costs
Direct costs; root canal treatment is believed to be a lengthy
and costly procedure, which is not supported by the public
insurance in Iran. Therefore, in deprived regions of Iran even
if the patient provides informed consent, the equipment and
materials for RCT is available (which is not in most cases), and
dental professionals are adequately trained, the only feasible
option would then be extraction of the involved tooth because
of the patients’ not being able to afford RCT. Indirect costs of
CEM/VPT were also compared to RCT. The number of visits
to the dental clinic for both treatment groups was considered.
Impact
To assess the impact of this new biotechnology in the
community at large, the percentage of patients requiring this
type of treatment need to be recorded. A literature review
conducted by the research team was not able to find studies
(conducted in Iran) which report the incidence of teeth with
established irreversible pulpitis requiring root canal treatment.
Therefore a cross sectional descriptive study, to elicit burden of
irreversible pulpitis among other classifications of pulpitis, was
performed. Studies that determine the incidence of this disease
require a specific number of samples and as there were no
previous data, the expected prevalence was taken to be 50% to
give the greatest sample requirement of 385 subjects.
Dental records of patients from Endodontic Department
of Shahid Beheshti Dental School were selected to form the
samples of this study. Patient records from this department
were selected on a randomized basis, as all patients with dental
pain and endodontic problems were initially referred there and
then redistributed among undergraduates or postgraduate
students. The patient records, radiographs and OPG which
were compiled by dental students (under the supervision of an
endodontist) and were analyzed by an endodontist and dental
public health PhD student (dentist). Inter-examiner agreement
regarding the diagnoses was confirmed. Records with missing
radiographs, vague results or inter-examiner disagreement
were disregarded; these were then replaced with other records.
The tooth number and type as well as the pulp and
periapical status were recorded for each sample. The pulpal
status was divided into four categories: normal, reversible
pulpitis, irreversible pulpitis, and necrosis. Periapical status
was also subdivided into: normal, acute apical periodontitis
(AAP), chronic apical periodontitis (CAP), acute apical
abscess, chronic apical abscess or condensing osteitis.
Results
Phase I: Main outcome measure
Using the CONSORT check list, results were internally
validated and deemed reliable; in addition, the randomized
clinical trial was graded as Level of Evidence 1 (LoE 1) and
significance of these results was evident.
Based on the reported randomized clinical trial, there
was no significant difference in preoperative pain levels
experienced between the two patient groups (VPT/CEM and
RCT) [25]. During the first 7 postoperative days, patients in
VPT/CEM group experienced less pain compared with the
RCT group (P>0.001). The greatest reduction in pain
occurred in the first 24 h in both groups; however, number of
patients reaching pain free status in the VPT/CEM group was
greater than the RCT group (73% vs. 48%, P<0.05).
Clinical success rates
Clinical success was based on the absence of signs and
symptoms of inflammation/infection as well as tenderness to
percussion. There was no significant difference between the
two groups at 6-month, 1- and 2-year follow-ups.
Radiographic success rates
Compared to RCT, the new biotechnology, VPT/CEM,
demonstrated greater success rates after one and two years
(1-year: 92.2% vs. 70.3%, P=0.001; 2-years: 86.7% vs. 79.5%,
P=0.053). As time passed the success rates became more
favorable in RCT group. While in CEM/VPT group the
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presence of preoperative radiographic periapical lesion did not
significantly affect the success rate, in RCT group it did [18].
Sensitivity analyses
To assess the sensitivity of radiographic success rate, worse case
analysis was used; that is, teeth which underwent VPT/CEM
but had uncertain status after one year were added to the VPT
failure subgroup, whereas , in RCT group, the uncertain
subgroup were added to the successful cases. This did not alter
the results of the chi-square statistical analyses [18].
Quality of treatment
The quality of treatment based on radiographic findings and
in accordance to modified Strindberg Criteria was
significantly different between the two groups (P<0.001) [27];
with 92.8% of VPT/CEM and only 66.3% of RCT cases
having achieved good quality treatment. Moreover there was
significant relationship between the quality of treatment and
one-year post operative radiographic success rates [18].
Phase II: Safety measure
The group agreed that VPT/CEM for teeth with irreversible
pulpitis need to meet six criteria. It was able to get 5 positive
and 1 negative responses at this stage of analyses.
a) Iatrogenic errors occurring during treatment (Positive)
Compared to RCT, VPT/CEM was considered a much
simpler treatment and therefore likely to have less
complications and procedural errors such as broken
instrument, ledge formation, canal transport/perforations or
hypochlorite accident. RCT has many more hazardous steps
increasing the risk of serious errors.
b) Pain experience (Positive)
Again VPT/CEM was assumed to significantly reduce post
operative pain. In addition, the amount of painkillers taken after
VPT/CEM was significantly less than the RCT group (P>0.001).
c) Radiographic requirement and x-ray radiation (Positive)
This item was considered to be lower for VPT/CEM
compared to RCT; as RCT usually requires working and
postoperative radiographs. Not only VPT/CEM will reduce
radiation dose for the patient and thus increases his/her
safety, but also may significantly reduce treatment costs.
d) Longevity of Tooth (Positive)
RCT increases the risk of tooth fracture due to removal of
significant amounts of tooth structure. RCT can initiate a
restorative spiral which overtime might result in tooth loss
and therefore a decrease in functionality and quality of life,
[28]. During VPT/CEM treatment a greater amount of tooth
structure is preserved and therefore the risk of tooth fracture
is considerably reduced.
e) Biocompatibility and non-carcinogenicity of materials
(Positive)
The committee pointed to previous studies which showed
that CEM cement is non-toxic and biocompatible which can
allow tissue regeneration [29, 30].
f) Ability to retreat in cases of failure (Negative)
General opinion was negative for this safety variable. Short-
or immediate term failure may occur due to two reasons: 1)
incorrect case selection and 2) failure of dentine bridge
formation at the canal orifice [31]. Whereas dentine bridge
formation does assume short-term success, in the long-term
if the VPT eventually fails and retreatment is required, the
canals would be blocked with a dentine bridge. Thus
retreatment may be difficult, if not impossible. The other
treatment options would be surgical endodontics (a high
cost treatment option requiring specific skills) or
extraction. A few members of the panel thought that access
to the root canals was still achievable as root canal
obliteration had not been seen beneath the canal orifices;
this was further supported by the two-year follow-ups of the
study [19].
Phase III: Organizational measures
Accessibility
Availability; this new biotechnology can be used both in
private practice and primary clinics as it does not require
any extra specialist skills (unlike molar RCT) or materials,
except for CEM cement which is readily available in Iran.
American Dental Association (ADA) has categorized RCT
of molars, prosthesis, orthodontics and surgery as
treatments requiring high levels of skill. On the other hand,
CEM cement pulpotomy does not require negotiation and
preparation of canals, obturation, and etc., therefore is
simpler to perform. Extra equipment is not also needed for
this technique unlike RCT, which may require operative
microscope, radiography unit, apex locator, rotary
instrument/motor, and so on. Also the diagnoses and
treatment plan may be carried out without radiographs just
based on sign and symptoms in deprived regions where
radiographic equipment is not available.
Feasibility; the above mentioned considerations and the
fact that general dentists could be easily trained (workshops
were nationally available as a 4-h course) made the treatment
more feasible than RCT. Radiographs are also not compulsory
for CEM/VPT and therefore treatment can be carried out with
basic dental amenities. Worldwide epidemiological research
shows that an average of 30-65% of RCTs that were carried out
by general dentists, failed [21].
Costs
Direct cost: immediate chair side cost for patients was recently
reported; CEM/VPT had significantly lower cost in Iran, i.e.
44.5 k per molar tooth compared to 171.5 k for RCT [19].
Indirect cost: the general consensus of the team was that
VPT/CEM involved less equipment, materials, travel costs,
specialist centers and radiography; therefore would be less
expensive. It was thought that patients would also be more likely
to choose a shorter and less expensive treatment than RCT and
therefore be more inclined to save teeth rather than extract
them. Root canal treatment often involves extensive restoration
of the tooth and possible subsequent laboratory made crown
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Table 1. Prevalence of different pulp status in endodontic patients
Pulp status Frequency Percent (%)
Normal 6 1.6
Reversible Pulpitis 10 2.6
Irreversible Pulpitis (IP) 232 60.4
Necrosis 136 35.4
Total 384 100
which adds additional costs to the therapy. Moreover, RCT and
crown restorations frequently require more than one visit, which
further increases the indirect costs and time spent.
According to the proposed agreed measures, the
discussion panel concluded that CEM/VPT was more easily
accessible, as the results for availability and cost were
favorable.
Impact
The records (including radiographs) of 385 patients that
attended the Endodontic Department of Shahid Beheshti
Dental School in 2010 for RCT were evaluated. The number
of teeth diagnosed with irreversible pulpitis or necrosis that
required RCT was recorded. A total of 203 (52.9%) were
maxillary and 181 (47.1%) were mandibular teeth. The
majority of cases were molars (42.4 %), followed by
premolars (38.5%), while anterior teeth and canines
consisted of only 19% of total treated teeth. The judges
disagreed on 7 cases (1.8% of total) which were excluded
from the analysis.
Sixty percent of treated teeth were diagnosed with
irreversible pulpitis and 35.4% with necrosis (Table 1). The
prevalence of irreversible pulpitis was 60.7%, 68.2% and
43.8% in molars, premolars and anterior teeth, respectively.
Premolars had the greatest diagnosis of irreversible pulpitis
(Table 2); the difference was statistically significant
(P>0.001). Only 29.8% of teeth diagnosed with irreversible
pulpitis had a radiographic apical lesion, whereas 52.2% of
necrotic teeth were diagnosed with chronic periapical
periodontitis. The percentage of teeth with pulp necrosis
compared to irreversible pulpitis in the three dental
categories were significantly different (P=0.001) based on
chi-square statistical test. The presence of periapical lesion in
necrotic teeth versus those with irreversibly inflamed pulps
were statistically different (P<0.001).
Discussion
This is the first study in dentistry that employed HTA to
evaluate a new biotechnology. CEM/VPT is a treatment
alternative for management of irreversible pulpitis; the long-
term efficacy and effectiveness of this new biotechnology has
been recently investigated. The first phase of this study showed
that based on short-term (post operative pain), intermediate-
(6-month) and long-term (1- and 2-year) outcomes, this new
biotechnology is successful even when patient factors are
considered [18, 19, 25]. The qualitative safety assessment of
VPT/CEM also showed that this is a reasonable treatment
Table 2. Prevalence of irreversible pulpitis or necrosis
Tooth
Irreversible pulpitis Necrosis
n % n %
1 10 38.5 15 57.7
2 11 40.7 14 51.9
3 11 55.9 9 45.0
4 29 65.9 14 31.8
5 72 69.2 26 25.0
6 81 60.0 51 37.8
7 18 64.3 7 25.3
option in irreversible pulpitis when compared with RCT as the
standard treatment. In fact, VPT/CEM can be more beneficial
treatment, with good safety margins. Retreatment may be
possible in the few failed cases as two year results show no
evidence of root canal obliteration.
The many mishaps that may occur during RCT, such as
iatrogenic perforation, patency at apical terminus and
extrusion of root fillings, reduce the longevity of root treated
teeth [32]. Moreover, there are strict radiographic and
clinical criteria, such as Strindberg, to indicate good
prognoses, and some general practitioners are not sufficiently
skilled to attain this standard in molar teeth. Many root canal
treatments would be termed failures radiographically. A
recent meta-analysis showed that 36% of endodontically
treated teeth have periradicular radiolucencies and 78% were
reported to be technically inadequate [33].
A novel study has illustrated that the longevity of teeth
treated with RCT, significantly increased when the mesial or
distal proximal walls were maintained and when the tooth in
question was not a molar. Therefore, in molar teeth a
conservative cavity preparation and CEM/VPT instead of
RCT may indeed increase their life span as pulp vitality and
tooth proprioception is maintained, and less tissue is
destroyed [34]. When the survival efficacy of the two
interventions is compared, two year follow-up in root canal
treated teeth is a good indicator of long-term success [7, 35,
36]. The results of recent trials showed that 6-month success
rates of CEM/VPT was similar to the one- and two-year
rates, however in the RCT arm, as time passed success rate of
the remaining root treated teeth increased [18, 19]. That is,
when root treated teeth are successful after 2 years, their
likelihood of further success increases.
Cytotoxicity, genotoxicity and carcinogenicity tests have
revealed that CEM is a biocompatible material similar to MTA
[21, 31, 34, 37]. One study compared CEM with IRM and
demonstrated that it was significantly more biocompatible [29]
and others showed good bio-compatible clinical/histological
responses when the material was used as a pulp cap or root-
end filling material [30, 38-45].
CEM/VPT is more easily applicable compared to the
more complex RCT, which is sometimes inadequately done
[33]. CEM/VPT is also less costly and requires less specialist
apparatus and materials, and therefore may have huge social
and economical implications on oral health and patients’
quality of life in both developing and developed nations.
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This study relied on the 2 year clinical outcomes of the
randomized clinical trials; several studies have shown that 2 year
outcome assessment is a sufficient prediction for the success or
failure of the endodontic treatment [7, 36]. VPT/CEM may
actually be a suitable treatment option for patients suffering
from painful irreversible pulpitis as it is a quick solution that
reduces pain more effectively than RCT. Also, it involves
biomaterials with no filing or toxic irrigation. Additionally,
radiography is not compulsory but advisable in this treatment
for diagnosis and follow-up. This means that CEM/VPT has
easier accessibility than RCT; however, the inability to retreat
these teeth in cases of failure has not yet been reported.
The impact of CEM/VPT on Iranian oral health is
significant when the percentage of patients suffering from
irreversible pulpitis presenting to Shahid Beheshti Dental
School is considered (60%); a value much higher than
patients with necrotic pulps. Considering that in the last 10
years values of DMFT in a sample of 506 teenage students in
Iran was relatively high (DMFT=1.8) [46], pulpotomy could
greatly assist oral health in Iran.
The availability of the new biotechnology was judged to
be far better due to less equipment, and training required. The
overall results including the organizational measures and
safety analyses can help to initiate adequate training and policy
making in primary healthcare centers in Iran. It must be noted
that training/education may incur an initial cost; however, the
overall lower expected costs, this treatment modality will be
more feasible than RCT in communities with limited funds.
Based on the results of present HTA, our suggestions
are: i) incorporate this into undergraduate curriculum and
into continuing professional education for qualified dentist;
ii) increasing patient awareness towards prevention and
pulpotomy instead of extraction in primary healthcare
centers; and iii) incorporate the VPT/CEM treatment in
dental insurance.
The similarities between Iran and other developing
countries may also have social implications on their oral
health policies and services [47].
Conclusion
There was high-quality and long-term evidence from
multicenter randomized clinical trials to support the use of
VPT/CEM new biotechnology instead of RCT for patients
suffering from irreversible pulpitis. Data relating to pain relief
effect, radiographic outcomes, safety, costs, availability,
accessibility and impact of VPT/CEM biotechnology,
demonstrated superiority of VPT/CEM over RCT. We can
conclude that VPT with a bio-regenerative material can be
recommended for general clinical practice worldwide.
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